With no evident side-effects that treatments like chemotherapy pose, this vaccine is effectual in combating a wide array of tumours. Through ten long years of trials and research carried out by Czechs, have finally evolved a distinctive method to develop this vaccine that can be used to treat several ailments like blood cancer, bowel cancer, skin cancer, ovarian cancer and reappearing tumours.

The treatment comes up to 5000 U.S. dollars per person with the effect of the vaccine lastly through the year. The initial prime hitch in using the vaccine being the significant amounts of time required and high-end equipment in super-specialty laboratories utilized in the process of making the vaccine, with the outcome of merely one vaccine in a week, no more than 50 vaccines being developed annually. However, these preliminary hurdles have been eventually overcome with the research touching a level where there is significant production.

Another crucial advance is the premier, globally available, effectual, anti-cancer vaccine OncoVAX(R) to treat colon cancer which first started in Europe. OncoVAX(R) is an effective immunotherapy treatment that has been successful conjugated through years of toiling by several scientists. It successfully averts an array of infective diseases by altering the body’s immune system in such a way that it prevents recurrence of the disease years post surgery and reduces death by more than 50%.

The vaccine, made by scientists, by making use of the tumour found in the body of the patient and giving the patient the vaccine three times a week, a month after the surgery.

BiovaxID, developed by the fruits of labour of Stanford University and the National Cancer Institute, is a personalized remedial vaccine that is effective in exclusively targeting cancerous white blood cells while leaving the healthy cells untouched. BiovaxID is the sole hybrid duo of human white blood cell with cancer cell, the anti-cancer vaccine, which is a high reliability vaccine playing the key role in mounting full blown and absolute attack against the cancer at the same time training the immune system for continued future defence.

The benefits of this miracle vaccine will continue to elude many third world countries for quite sometime, where these vaccines are still not available.

Scientists at Newcastle University in joint endeavor with the North East England Stem Cell Institute have devised a radical approach to obtain what they proclaim as sperm cells from nascent stem cells.

Stem cells have the ability to transform into any cell in the body. Research senior at Newcastle University, Karim Nayernia on Wednesday remarked on the immense versatility of stem cells, stating how the procedure would provide an insight to the researchers on the way the sperms were produced, that would go a long way in evolving effective treatments for male infertility.

The revolutionary research was circulated on Wednesday in the Stem Cells and Development periodical. Many professionals in the field have been quite sceptical in regards to this research proclaiming the laboratory generated sperms were visibly nonstandard.

Allan Pacey, a senior andrology lecturer in University of Sheffield was uncertain about the publication stating that the sperms derived from the emergent stem cells could be precisely called spermatozoa. Pacey contradicted Nayernia’s research by proclaiming that the artificially generated sperms lacked the characteristic nature, mobility and utility.

A physiology and reproduction professor of University of Cambridge, Azim Surani believed the sperms developed by the Nayernia and his accomplices were far off from being genuine sperm cells.

Some like Robin Lovell-Badge, a stem cell specialist in the National Institute of Medical Research believed that in spite of the negativity displayed by many towards this research, the Newcastle Team have made significant steps forward in deriving human sperms from embryonic stem cells.

Nayernia defended his claim by stating that the laboratory derives sperms demonstrated all the attributes of the innate form. Nayernia had stated that their latest endeavor was not just utilizing the sperms produced to fertilize eggs but as a means to unlock new arenas of research and development.

Nayernia stated that the creation of embryos using laboratory derived sperms is barred by UK Law.

While some law makers were of the view that provisos should be introduced to permit sperm cells derived from stem cells to be used in trials for prospective infertility cure treatments.

Nanoparticles are sub-sized solid colloidal materials which bear the active code in suspended, encapsulated form adhered to them and utilised for curative disease management. This nano sizing or particle size diminution of drugs has immense benefits right from zeroing on the particular cell without affecting the contiguous cells, greater surface area and increased solubility leads to faster commencement of the remedial action.

Their sub-micron size facilitates the nanoparticles to infiltrate deeper into the tissues via delicate capillary systems, easily passing through to the epithelial lining like the liver and thus effectually absorbed by those cells. The time and extent of discharge of the curative agent from the nanoparticles can be controlled, thus optimizing its effect. The delivery to remote target cells is administered either through a least invasive catheter procedure or binding to a bio definite ligand that will carry it unswervingly to the specified organ or tissue in question. This is a potential solution to cure psychiatric turmoil, cancer, gene therapy amongst many others.

An idyllic nano material is one that is miniature enough to permeate the target cells, flexible enough to be used in a host of maladies. Dendrimers with their spherical structure and series of chemical-based bullets built into a smallish core molecule serves as effective nano particles. Dendrimers help identify cancerous growth, detect the root cause, effectually transport the drug to the target cells, and provide information on the site of the tumor and the effect of the therapy on the cells.

Stubborn, hard-healing wounds in diabetics who many times suffer from diabetic foot are effectively treated with dermal fibroblasts that are implanted on multi-dimensional bio-soak able gibbets that are a kind of nano particle technology.

Those with lumbar and degenerative disc problem are treated with titanium based spinal synthesis cage with collagen dab that is a kind of nano technology.

Tumors can be destroyed by a light sensitive drugs triggered by LED devices or the use of bio synthetic pancreas that will gauge and produce insulin and a fine polymer sheet infused with live islets of Langerhans embedded into the peritoneal cavity.

Those with heart ailments like defective-degenerative valve or muscle, arrhythmic heart will benefit immensely from the silicon microchips which are drug warehouses that are gold or polymer covered which involuntarily releases necessary medications at desired time intervals.

Miniature versions of the HIV virus are taken and modified in laboratories to develop synthetic copies. The process does not involve using the whole or live vaccine. The vaccine being tested will have the ability to effectively produce either cytotoxic T cells or antibodies that will aid in combating the infection.

Types of investigation HIV vaccine strategies:

• Peptide vaccines have been developed from minuscule pieces of proteins taken from the HIV virus.
• A recombinant sub-unit protein vaccine which is under way makes use of bigger parts of proteins that are situated on the surface of the HIV virus. The recombinant vaccine versions gp 120, gp 140 and gp 160 developed by genetic engineering processes effectively boost the immune system and solely elicit stronger immune responses.
• Another promising approach called the live vector vaccine, involves the use of non-HIV viruses that are artificially engineered to carry genes encoding the HIV proteins. These genes are then inserted into yet another vector which carries them into the body cells. The genes produce proteins which are similar to those found on the surface of the HIV virus. This vaccine type bears a resemblance to the HIV virus but is not harmful.
• The DNA vaccine utilizes duplicates of diminutive number of HIV genes that are inserted into pieces of DNA called plasmid. The HIV genes will produce proteins quite similar to those from the real HIV.
• Vaccine combos have been developed which utilize any two vaccines in quick succession to create a stronger immune response. This technique is also called the prime boost strategy.
• The pseudo-virion vaccine which is a virus like particle vaccine is non-infectious and harmless HIV look-alike that has one or more but not all the HIV proteins.

Meanwhile researchers have come up with a daily single dose oral preventative approach with potent antiretrovirals. The medicine will prevent the illness as it will be in the blood stream and will help reduce new infections among people at greater risk of exposure. Tenofovir and combo duo pill of tenofovir plus emtricitabine have been established as safe for reducing the risk of HIV infection.

Many organisations involved in stem cell banking research have come with the novel idea of banking menstrual blood. Studies have revealed that menstrual blood is a rich source of stem cells. The monthly cycle is the result of shedding of the endometrial lining of the uterus, which redevelops every month. In this unique way of collecting stem cells, the woman would be given a collection kit that would consist of a silicone pod and collection tubes. The blood would be processed and preserved in liquid nitrogen chambers at very low temperatures.

The silicone pod is essentially a cone shaped structure made of medical grade silicon. The sides of the pod are to be pressed together and folded into half. After holding the pod which now resembles a cup-like structure is then inserted deep into the vagina, with only the stem remaining out. The stem can be then used to pull out the pod and the liquid can be drained for stem cell cultivation.

This silicone pod is also an extremely cost-effective and convenient option for women who have the bane of buying and using monthly tampons and pads. The pod costs a merely around 20$ and can be used for 2yrs with regular cleaning, with the pack stating a use of up to 5 yrs. These soft, flexible and quite comfortable silicon cups can be inserted to hold monthly periods for a whole day, after which it can be removed washed and reused.

These cups were first patented in US in 1930, but did not manage to conjugate much popularity due to the latex or plastic make which did not go down well with quite a few women. But after the silicon cups were launched in the 1990’s, a lot of women have eventually started using them due their several advantages. These pods made of medical silicon grade are FDA-approved and high on the comfort and safety factor.

Several vaccines in their experimental stages have been tested against the form of the parasite that resides in the human body. The biggest hurdle the vaccines faces is that the falciparum cells are able to escape the clutches of the human immune system by taking cover in the liver and blood cells. When these cells are in the human body, they mostly exist in the asexual form. They then transform into the sexual form in the mosquito’s gut and embed themselves in the gut lining of the mosquito, which eventually discretely makes its way to the salivary glands, where it is transmitted after a bite.

An exceptional malaria vaccine which is extracted from the saliva of the infected mosquitoes has recently been successfully cleared by the US FDA to be tried on people. This vaccine unlike other vaccines in developmental stage, is actually the frail version of the whole malaria causing parasite, falciparum. The vaccine which has been developed by a company called Sanaria based in Rockville, reduces the effect of the parasite by feeding human-infected blood to the mosquitoes. These mosquitoes were then killed by exposing them to radiations potent enough to cripple the parasite. The saliva containing the frail parasite is then extracted from the dead mosquitoes. Though this method, one can expect an average production of about 1200 vaccine doses per hour.

The aim is that when the human immune system is exposed to something that resembles the parasite but in relatively harmless, the body will counteract it with a much stronger resistance and immunity than with already existing vaccines that are based on tiny elements of the parasite.

Recipients who were given trial versions of the spit vaccine, before the manufacturing process commenced, were fully protected against the disease for more than 3 years. By June 2009, one can expect full-fledged trials and eventual successful get through; progressing from country to country, till malaria is totally eradicated for good.

For many years, the currently subsisting radiation treatments entailed prolonged course of action and the use of agonizing braces or manacles. The inimitable side effects are guaranteed damage to the healthy organs during treatment. Some tumours were fatal or the peril of undertaking surgery was huge, leaving the patient no way out.

This advanced stereotactic robot guided surgery aims at tumours with impeccable exactness. It delivers elevated doses of emission, while routing clear of healthy tissues. What makes this treatment so exceptional and different from traditional systems, is its effectual motion tracking capacity, on similar lines to speed directed missile systems. This procedure synchronises the movement of the robotic arm with the patient’s breathing patterns so that tumours can be treated with millimetre exactness. There are some tumours too multifarious to be operated on by traditional techniques, like those that develop in the spinal cord, pancreas, lungs, liver and prostrate. These tumours are successfully treated upon non-invasively and painlessly.

The treatment significantly decreases the treatment time from about more than a month to just about a week, with a session a day that would go on for half to more than an hour. The superlative level of exactness leads to fewer side effects, thus the person concerned can swiftly catch up with his routine task with great ease.

The initial step of the procedure involves the insertion of miniature gold seeds into the tumour using CT scan. This is used to identify the exact location of the tumour during the treatment. A time period of seven days is set aside to ensure the proper positioning of the gold seeds.

The process in the treatment involves set-up and image scanning. In this the patient is properly positioned on a customised body cradle for unswerving placement. A synchrony vest is attached to the patient to associate breathing patterns and chest movement. The data generated herewith is what facilitates exact and safe delivery of radiation. The patient with the vest worn, then goes through an array of CT scans to aid the Cyberknife team to establish the real size, shape and location of the tumour. The CT scan is needed to completely monitor the location of the tumour to the adjoining organs.

During the final course of the treatment, the patient is fitted with the Synchrony vest and cradle and placed properly. The Cyberknife’s computer managed robot arm then spans through the patient’s body to deliver radiation to the exact location.

This treatment is truly a boon to mankind, many of whom had lost hope to survive from this deadly disease.